|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4470461A
(en)
|
1982-09-30 |
1984-09-11 |
Phillips Petroleum Company |
Organic nitro compounds as cosurfactants in enhanced oil recovery processes
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
FI903489A7
(fi)
|
1988-11-11 |
1990-07-10 |
Medical Res Council |
Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
AU649066B2
(en)
|
1990-07-25 |
1994-05-12 |
Syngene, Inc. |
Circular extension for generating multiple nucleic acid complements
|
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
|
GB9114948D0
(en)
|
1991-07-11 |
1991-08-28 |
Pfizer Ltd |
Process for preparing sertraline intermediates
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
US5858784A
(en)
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
|
US5633234A
(en)
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
|
WO1994025591A1
(en)
|
1993-04-29 |
1994-11-10 |
Unilever N.V. |
PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
|
|
US5773244A
(en)
|
1993-05-19 |
1998-06-30 |
Regents Of The University Of California |
Methods of making circular RNA
|
|
FR2709309B1
(fr)
|
1993-08-25 |
1995-11-10 |
Centre Nat Rech Scient |
Compositions cellulaires, préparation et utilisations thérapeutiques.
|
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
|
US5641863A
(en)
|
1993-09-30 |
1997-06-24 |
University Of Pennsylvania |
Chimeric IgG Fc receptors
|
|
US5639642A
(en)
|
1994-06-16 |
1997-06-17 |
Novo Nordisk A/S |
Synthetic leader peptide sequences
|
|
US6300090B1
(en)
|
1994-07-29 |
2001-10-09 |
The Rockefeller University |
Methods of use of viral vectors to deliver antigen to dendritic cells
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5766903A
(en)
|
1995-08-23 |
1998-06-16 |
University Technology Corporation |
Circular RNA and uses thereof
|
|
US6150160A
(en)
|
1995-11-16 |
2000-11-21 |
The John Hopkins University |
Compositions and methods of use of mammalian retrotransposons
|
|
US20030121063A1
(en)
|
1995-11-16 |
2003-06-26 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of use of mammalian retrotransposons
|
|
US6734014B1
(en)
|
1996-02-08 |
2004-05-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods and compositions for transforming dendritic cells and activating T cells
|
|
WO1999042564A2
(en)
|
1998-02-20 |
1999-08-26 |
The Rockefeller University |
Apoptotic cell-mediated antigen presentation to dendritic cells
|
|
US6210931B1
(en)
|
1998-11-30 |
2001-04-03 |
The United States Of America As Represented By The Secretary Of Agriculture |
Ribozyme-mediated synthesis of circular RNA
|
|
US6576463B1
(en)
|
1999-01-15 |
2003-06-10 |
The Regents Of The University Of California |
Hybrid vectors for gene therapy
|
|
WO2001030965A2
(en)
|
1999-10-28 |
2001-05-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of in vivo gene transfer using a sleeping beauty transposon system
|
|
WO2001083713A2
(en)
|
2000-04-28 |
2001-11-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
The use of tolerogenic dendritic cells for enhancing tolerogenicity in a host and methods for making the same
|
|
US7176243B2
(en)
|
2000-06-02 |
2007-02-13 |
The General Hospital Corporation |
CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
|
|
US7446179B2
(en)
|
2000-11-07 |
2008-11-04 |
City Of Hope |
CD19-specific chimeric T cell receptor
|
|
US8709412B2
(en)
|
2001-06-29 |
2014-04-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulation of TIM receptor activity in combination with cytoreductive therapy
|
|
US20060183226A1
(en)
|
2002-01-31 |
2006-08-17 |
Haruhiko Fujiwara |
Methods for retrotransposing long interspersed elements (lines)
|
|
AU2003219805B2
(en)
|
2002-02-15 |
2009-06-04 |
Eisai Inc. |
Electroporation methods for introducing bioactive agents into cells
|
|
US20080254027A1
(en)
|
2002-03-01 |
2008-10-16 |
Bernett Matthew J |
Optimized CD5 antibodies and methods of using the same
|
|
CA2488328C
(en)
|
2002-06-05 |
2017-03-07 |
Kevin L. Rozwadowski |
Retrons for gene targeting
|
|
AU2003241252A1
(en)
|
2002-06-06 |
2003-12-22 |
Immunicum Ab |
New method and composition for producing a cellular allogeneic vaccine
|
|
US20060239962A1
(en)
|
2002-12-04 |
2006-10-26 |
Banchereau Jacques F |
Rapid one-step generation of antigen loaded dendritic cell vaccine from precursors
|
|
US20070037759A1
(en)
|
2003-02-07 |
2007-02-15 |
Administrators Of The Tulane Educational Fund, The |
Mammalian retrotransposable elements
|
|
US8007805B2
(en)
|
2003-08-08 |
2011-08-30 |
Paladin Labs, Inc. |
Chimeric antigens for breaking host tolerance to foreign antigens
|
|
US8198020B2
(en)
|
2003-08-22 |
2012-06-12 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for enhancing phagocytosis or phagocyte activity
|
|
US7709625B2
(en)
|
2004-06-10 |
2010-05-04 |
The Board Of Regents Of The University Of Texas |
Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy
|
|
US8252587B2
(en)
|
2004-10-25 |
2012-08-28 |
Celerant Therapeutics, Inc. |
Methods of expanding myeloid cell populations and uses thereof
|
|
GB2421948A
(en)
*
|
2004-12-30 |
2006-07-12 |
Ist Superiore Sanita |
Retrotransposon inhibition to treat cancer
|
|
US20060188891A1
(en)
|
2005-02-23 |
2006-08-24 |
Bickmore William D Jr |
Methods and apparatus for controlling DNA amplification
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
US20090191202A1
(en)
|
2005-09-29 |
2009-07-30 |
Jamieson Catriona Helen M |
Methods for manipulating phagocytosis mediated by CD47
|
|
US7926300B2
(en)
|
2005-11-18 |
2011-04-19 |
Cree, Inc. |
Adaptive adjustment of light output of solid state lighting panels
|
|
EP2004237A1
(en)
|
2006-04-03 |
2008-12-24 |
Keele University |
Targeted therapy
|
|
WO2007130543A2
(en)
|
2006-05-04 |
2007-11-15 |
Abmaxis Inc. |
Method for producing stable mammalian cell lines producing high levels of recombinant proteins
|
|
WO2008011599A2
(en)
|
2006-07-20 |
2008-01-24 |
Gourmetceuticals, Llc |
Phosphorylated glucomannan polysaccharide for receptor mediated activation and maturation of monocyte-derived dendritic cells
|
|
US7833789B2
(en)
|
2006-08-01 |
2010-11-16 |
Fondazione Centro San Raffaele Del Monte Tabor |
Monocyte cell
|
|
CN1951499A
(zh)
|
2006-10-09 |
2007-04-25 |
中国农业大学 |
一种细胞免疫疫苗及其制备方法
|
|
US10155038B2
(en)
|
2007-02-02 |
2018-12-18 |
Yale University |
Cells prepared by transient transfection and methods of use thereof
|
|
US9228180B2
(en)
|
2007-07-04 |
2016-01-05 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Polypeptide variants of sleeping beauty transposase
|
|
EP2055784A1
(en)
|
2007-10-31 |
2009-05-06 |
Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Prof. Dr. Johannes Löwer |
Controlled activation of non-LTR retrotransposons in mammals
|
|
PT3056515T
(pt)
|
2008-01-15 |
2019-07-19 |
Univ Leland Stanford Junior |
Métodos para manipulação da fagocitose mediada por cd47
|
|
US9034325B2
(en)
|
2008-07-22 |
2015-05-19 |
Ablynx N.V. |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
US20110250203A1
(en)
|
2008-08-29 |
2011-10-13 |
Symphogen A/S |
Anti-cd5 antibodies
|
|
AU2009292996B2
(en)
|
2008-09-22 |
2015-04-23 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
|
|
US9080211B2
(en)
|
2008-10-24 |
2015-07-14 |
Epicentre Technologies Corporation |
Transposon end compositions and methods for modifying nucleic acids
|
|
EP2248903A1
(en)
*
|
2009-04-29 |
2010-11-10 |
Universitat Autònoma De Barcelona |
Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
|
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
|
JP5975983B2
(ja)
|
2010-04-16 |
2016-08-23 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
固形腫瘍を処置するための方法
|
|
WO2012005763A1
(en)
|
2010-07-06 |
2012-01-12 |
The Scripps Research Institute |
Use of myeloid-like progenitor cell populations to treat tumors
|
|
EP3115373B1
(en)
|
2010-09-08 |
2019-08-28 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Chimeric antigen receptors with an optimized hinge region
|
|
WO2012043651A1
(ja)
|
2010-09-30 |
2012-04-05 |
国立大学法人 熊本大学 |
ミエロイド系血液細胞の製造方法
|
|
US9206479B2
(en)
|
2011-02-09 |
2015-12-08 |
University Of Rochester |
Methods and compositions related to Staufen 1 binding sites formed by duplexing Alu elements
|
|
WO2012133947A1
(en)
|
2011-03-30 |
2012-10-04 |
Riken |
Functional nucleic acid molecule and use thereof
|
|
KR20220025112A
(ko)
|
2011-06-08 |
2022-03-03 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Mrna 전달을 위한 지질 나노입자 조성물 및 방법
|
|
EP2753345B1
(en)
|
2011-09-06 |
2016-07-13 |
Agency For Science, Technology And Research |
Polypeptide vaccine
|
|
JP6053688B2
(ja)
|
2011-10-07 |
2016-12-27 |
国立大学法人三重大学 |
キメラ抗原受容体
|
|
US9149519B2
(en)
|
2012-01-17 |
2015-10-06 |
New York University |
Chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism comprising the simian immunodeficiency virus (SIV) minimal Vpx packaging domain
|
|
ME03512B
(me)
|
2012-02-06 |
2020-04-20 |
Inhibrx Inc |
Cd47 antitijela i postupci za njihovu upotrebu
|
|
US20140140989A1
(en)
|
2012-02-06 |
2014-05-22 |
Inhibrx Llc |
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
|
|
EP2814846B1
(en)
|
2012-02-13 |
2020-01-08 |
Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
EP2753365B1
(en)
|
2012-02-14 |
2017-03-22 |
Loma Linda University |
Agents for treating inflammation-related conditions and diseases
|
|
EP2639313A1
(en)
|
2012-03-14 |
2013-09-18 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
High-resolution transcriptome of human macrophages
|
|
SG10201806573TA
(en)
|
2012-05-25 |
2018-09-27 |
Cellectis |
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
|
|
CN103483452B
(zh)
|
2012-06-12 |
2021-08-13 |
上海细胞治疗集团有限公司 |
双信号独立的嵌合抗原受体及其用途
|
|
PT2692865E
(pt)
|
2012-07-30 |
2015-02-06 |
Nbe Therapeutics Llc |
Identificação mediada por transposição de proteínas funcionais ou de ligação específicas
|
|
US20140037606A1
(en)
|
2012-08-06 |
2014-02-06 |
Eyal Amiel |
Cell-based, anti-cancer vaccines
|
|
RU2729401C2
(ru)
|
2012-10-02 |
2020-08-06 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
Композиции и способы для иммунотерапии
|
|
MX2015007446A
(es)
|
2012-12-12 |
2015-12-07 |
Vasculox Inc |
Anticuerpos terapeuticos para cd47.
|
|
US9221908B2
(en)
|
2012-12-12 |
2015-12-29 |
Vasculox, Inc. |
Therapeutic CD47 antibodies
|
|
SG10201706383XA
(en)
|
2013-02-06 |
2017-09-28 |
Inhibrx Lp |
Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereof
|
|
WO2014121840A1
(en)
|
2013-02-07 |
2014-08-14 |
Medizinische Hochschule Hannover |
Induced dendritic cells and uses thereof
|
|
IL298125A
(en)
|
2013-02-26 |
2023-01-01 |
Memorial Sloan Kettering Cancer Center |
Preparations and methods for immunotherapy
|
|
WO2014134412A1
(en)
|
2013-03-01 |
2014-09-04 |
Regents Of The University Of Minnesota |
Talen-based gene correction
|
|
US20160145348A1
(en)
|
2013-03-14 |
2016-05-26 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to modify cells for therapeutic objectives
|
|
ES2769574T3
(es)
|
2013-03-15 |
2020-06-26 |
Michael C Milone |
Reconocimiento de células citotóxicas con receptores quiméricos para inmunoterapia adoptiva
|
|
US20160250258A1
(en)
|
2013-10-31 |
2016-09-01 |
Fred Hutchinson Cancer Research Center |
Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
|
|
SG10201902571VA
(en)
|
2013-12-25 |
2019-04-29 |
Daiichi Sankyo Co Ltd |
Anti-trop2 antibody-drug conjugate
|
|
DK3105335T3
(da)
|
2014-02-14 |
2020-01-13 |
Univ Texas |
Kimære antigenreceptorer og fremgangsmåder til fremstilling heraf
|
|
WO2015138600A2
(en)
|
2014-03-11 |
2015-09-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anti sirp-alpha antibodies and bi-specific macrophage enhancing antibodies
|
|
US20170233452A1
(en)
|
2014-04-23 |
2017-08-17 |
Immusoft Corporation |
Chimeric antigen receptors specific to avb6 integrin and methods of use thereof to treat cancer
|
|
CN104004095B
(zh)
|
2014-06-04 |
2016-11-23 |
博生吉医药科技(苏州)有限公司 |
一种cd7纳米抗体、其编码序列及应用
|
|
AU2015289656A1
(en)
|
2014-07-16 |
2017-02-16 |
Modernatx, Inc. |
Circular polynucleotides
|
|
AU2015292744C1
(en)
|
2014-07-21 |
2021-01-21 |
Novartis Ag |
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
|
|
WO2016016343A1
(en)
|
2014-07-31 |
2016-02-04 |
Cellectis |
Ror1 specific multi-chain chimeric antigen receptor
|
|
EP3712171A1
(en)
|
2014-08-19 |
2020-09-23 |
Novartis AG |
Treatment of cancer using a cd123 chimeric antigen receptor
|
|
WO2016030501A1
(en)
*
|
2014-08-28 |
2016-03-03 |
Centre National De La Recherche Scientifique - Cnrs - |
Synthetic alu-retrotransposon vectors for gene therapy
|
|
DK3186284T3
(da)
|
2014-08-28 |
2022-05-09 |
Bioatla Inc |
Betinget aktive kimæriske antigenreceptorer til modificerede t-celler
|
|
WO2016040441A1
(en)
|
2014-09-09 |
2016-03-17 |
Unum Therapeutics |
Chimeric receptors and uses thereof in immune therapy
|
|
WO2016038168A1
(en)
|
2014-09-10 |
2016-03-17 |
Miltenyi Biotec Gmbh |
A cell population for use in treting cancer
|
|
KR20240056629A
(ko)
|
2014-09-28 |
2024-04-30 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
자극성 및 비자극성 골수성 세포의 조절
|
|
AU2015330017A1
(en)
|
2014-10-07 |
2017-04-27 |
Cellectis |
Method for modulating car-induced immune cells activity
|
|
MA41538A
(fr)
|
2014-10-17 |
2017-12-26 |
Baylor College Medicine |
Cellules immunitaires bipartites et tripartites de signalisation
|
|
CN122564053A
(zh)
|
2014-10-31 |
2026-08-14 |
麻省理工学院 |
递送生物分子至免疫细胞
|
|
WO2016081423A1
(en)
|
2014-11-18 |
2016-05-26 |
Janssen Pharmaceutica Nv |
Cd47 antibodies, methods, and uses
|
|
US11041158B2
(en)
|
2014-12-22 |
2021-06-22 |
AgBiome, Inc. |
Optimization methods for making a synthetic gene
|
|
WO2016126608A1
(en)
|
2015-02-02 |
2016-08-11 |
Novartis Ag |
Car-expressing cells against multiple tumor antigens and uses thereof
|
|
HRP20220890T1
(hr)
|
2015-02-06 |
2022-10-14 |
National University Of Singapore |
Postupci za povećanje učinkovitosti terapijskih imunosnih stanica
|
|
WO2016130845A1
(en)
|
2015-02-11 |
2016-08-18 |
Loma Linda University |
A method for utilizing engineered dendritic cells to induce gut-homing regulatory t cells and treat gut inflammation
|
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
|
EP3262166A4
(en)
|
2015-02-24 |
2018-08-15 |
The Regents of The University of California |
Binding-triggered transcriptional switches and methods of use thereof
|
|
CA2977106A1
(en)
|
2015-02-27 |
2016-09-01 |
Icell Gene Therapeutics Llc |
Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof
|
|
CN107708710A
(zh)
|
2015-03-17 |
2018-02-16 |
嵌合体生物工程公司 |
Smart CAR装置,DE CAR多肽,Side CAR及其使用
|
|
WO2016156557A1
(en)
*
|
2015-04-03 |
2016-10-06 |
Alienor Farma |
Monoclonal antibody to human line-1 orf2 protein and method for early detection of transforming cells in pre-neoplastic tissues of a human subject
|
|
MA41962A
(fr)
|
2015-04-23 |
2018-02-28 |
Baylor College Medicine |
Récepteur antigénique chimérique ciblant le cd5 pour une thérapie adoptive à base de cellules t
|
|
DK3298043T3
(da)
|
2015-05-18 |
2021-02-15 |
Ab Initio Biotherapeutics Inc |
SIRP-polypeptidsammensætninger og fremgangsmåder til anvendelse
|
|
US10434153B1
(en)
|
2015-05-20 |
2019-10-08 |
Kim Leslie O'Neill |
Use of car and bite technology coupled with an scFv from an antibody against human thymidine kinase 1 to specifically target tumors
|
|
GB201509413D0
(en)
|
2015-06-01 |
2015-07-15 |
Ucl Business Plc |
Fusion protein
|
|
WO2016196612A1
(en)
|
2015-06-01 |
2016-12-08 |
The Rockefeller University |
Anti-tumor agents and methods of use
|
|
AU2016279062A1
(en)
|
2015-06-18 |
2019-03-28 |
Omar O. Abudayyeh |
Novel CRISPR enzymes and systems
|
|
US20190008897A1
(en)
|
2015-07-22 |
2019-01-10 |
University Of Washington |
Compositions and methods for producing pro-inflammatory macrophages
|
|
JP7032304B2
(ja)
|
2015-07-28 |
2022-03-08 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
キメラ抗原受容体を発現する改変された単球／マクロファージおよびその使用
|
|
AU2016303497A1
(en)
|
2015-07-31 |
2018-03-01 |
Tarveda Therapeutics, Inc. |
Compositions and methods for immuno-oncology therapies
|
|
EP4339287A3
(en)
|
2015-07-31 |
2024-05-22 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
|
RU2740672C2
(ru)
|
2015-08-07 |
2021-01-19 |
ЭйЭлЭкс Онколоджи Инк. |
Конструкции, имеющие sirp-альфа домен или его вариант
|
|
US11352439B2
(en)
|
2015-08-13 |
2022-06-07 |
Kim Leslie O'Neill |
Macrophage CAR (MOTO-CAR) in immunotherapy
|
|
SG10201913151TA
(en)
|
2015-09-09 |
2020-03-30 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Genetic engineering of macrophages for immunotherapy
|
|
EP3653717B1
(en)
|
2015-09-16 |
2022-11-09 |
T-CURX GmbH |
Improved transposon system for gene delivery
|
|
AU2016325384B2
(en)
|
2015-09-22 |
2021-07-22 |
Julius-Maximilians-Universitat Wurzburg |
A method for high level and stable gene transfer in lymphocytes
|
|
CN105154473B
(zh)
|
2015-09-30 |
2019-03-01 |
上海细胞治疗研究院 |
一种高效安全的转座子整合系统及其用途
|
|
EP3334764A2
(en)
|
2015-10-13 |
2018-06-20 |
Brigham Young University |
Macrophage chimeric antigen receptor (moto-car) in imunotherapy
|
|
WO2017083441A1
(en)
|
2015-11-09 |
2017-05-18 |
Aperisys, Inc. |
Modified immune cells and uses thereof
|
|
US10946042B2
(en)
|
2015-12-01 |
2021-03-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for selective phagocytosis of human cancer cells
|
|
EP3202783A1
(en)
|
2016-02-02 |
2017-08-09 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Engineered antigen presenting cells and uses thereof
|
|
WO2017136633A1
(en)
|
2016-02-04 |
2017-08-10 |
Duke University |
Cell-based vaccine compositions and methods of use
|
|
WO2017133175A1
(en)
|
2016-02-04 |
2017-08-10 |
Nanjing Legend Biotech Co., Ltd. |
Engineered mammalian cells for cancer therapy
|
|
GB201602473D0
(en)
|
2016-02-11 |
2016-03-30 |
Horizon Discovery Ltd |
Replicative transposon system
|
|
US9820350B2
(en)
|
2016-02-19 |
2017-11-14 |
Cooper Technologies Company |
Configurable lighting system
|
|
US20170275665A1
(en)
|
2016-02-24 |
2017-09-28 |
Board Of Regents, The University Of Texas System |
Direct crispr spacer acquisition from rna by a reverse-transcriptase-cas1 fusion protein
|
|
US10617749B1
(en)
|
2016-02-24 |
2020-04-14 |
Duke University |
Composition of matter and methods for alteration of dendritic cell metabolism to augment cancer vaccine efficacy
|
|
US20200063157A9
(en)
|
2016-02-26 |
2020-02-27 |
Poseida Therapeutics, Inc. |
Transposon system and methods of use
|
|
EP3219803A1
(en)
|
2016-03-15 |
2017-09-20 |
Max-Delbrück-Centrum für Molekulare Medizin |
Enhanced sleeping beauty transposons, kits and methods of transposition
|
|
WO2019055946A1
(en)
|
2017-09-18 |
2019-03-21 |
F1 Oncology, Inc. |
METHODS AND COMPOSITIONS FOR THE GENETIC MODIFICATION AND EXPANSION OF LYMPHOCYTES AND THE REGULATION OF THE ACTIVITY THEREOF
|
|
US20180186855A1
(en)
|
2016-03-23 |
2018-07-05 |
Alector Llc |
Chimeric receptors and methods of use thereof
|
|
US20190112380A1
(en)
|
2016-03-29 |
2019-04-18 |
University Of Southern California |
Chimeric antigen receptors targeting cancer
|
|
WO2017184553A1
(en)
|
2016-04-18 |
2017-10-26 |
Baylor College Of Medicine |
Cancer gene therapy targeting cd47
|
|
US10875919B2
(en)
|
2016-04-26 |
2020-12-29 |
Alector Llc |
Chimeric receptors and methods of use thereof
|
|
US11390658B2
(en)
|
2016-06-06 |
2022-07-19 |
St. Jude Children's Research Hospital |
Anti-CD7 chimeric antigen receptor and method of use thereof
|
|
US11130951B2
(en)
|
2016-06-09 |
2021-09-28 |
The General Hospital Corporation |
Modulating the cellular stress response
|
|
AU2017283713B2
(en)
|
2016-06-17 |
2021-04-08 |
Massachusetts Institute Of Technology |
Type VI CRISPR orthologs and systems
|
|
CN107523545A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抗体的杀伤性细胞及其用途
|
|
EP3504244A4
(en)
|
2016-08-26 |
2020-08-19 |
Agency for Science, Technology and Research |
MACROPHAGE-STIMULATING PROTEIN RECEPTOR ANTIBODIES (OR OF NANTAIS ORIGINAL RON-RECEPTOR) AND THEIR USES
|
|
JOP20190009A1
(ar)
|
2016-09-21 |
2019-01-27 |
Alx Oncology Inc |
أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها
|
|
WO2018064076A1
(en)
|
2016-09-27 |
2018-04-05 |
Cero Therapeutics, Inc. |
Chimeric engulfment receptor molecules
|
|
EP3518944A4
(en)
|
2016-09-30 |
2020-06-17 |
Baylor College of Medicine |
ADAPTIVE CHIMERIC ANTIGENT RECEPTOR T-CELL DESIGN
|
|
US11376332B2
(en)
|
2016-10-15 |
2022-07-05 |
Baylor College Of Medicine |
Platform for enhanced targeted delivery
|
|
WO2018073394A1
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Cell death inducing chimeric antigen receptors
|
|
EP3529276A4
(en)
|
2016-10-21 |
2020-06-17 |
Arch Oncology, Inc. |
CD47 THERAPEUTIC ANTIBODIES
|
|
EP3535291A1
(en)
|
2016-11-01 |
2019-09-11 |
Genmab B.V. |
Polypeptide variants and uses thereof
|
|
WO2018089860A1
(en)
|
2016-11-11 |
2018-05-17 |
2D Genomics Inc. |
Methods for processing nucleic acid samples
|
|
CN110325549B
(zh)
|
2016-12-09 |
2024-03-08 |
艾利妥 |
抗SIRPα抗体及其使用方法
|
|
KR102993694B1
(ko)
|
2016-12-09 |
2026-07-22 |
더 브로드 인스티튜트, 인코퍼레이티드 |
Crispr 이펙터 시스템 기반 진단
|
|
CA3049791A1
(en)
|
2017-01-27 |
2018-08-02 |
Silverback Therapeutics, Inc. |
Tumor targeting conjugates and methods of use thereof
|
|
KR102708285B1
(ko)
|
2017-03-13 |
2024-09-20 |
포세이다 테라퓨틱스, 인크. |
조혈 줄기세포의 선택적 제거 및 대체를 위한 조성물 및 방법
|
|
CN111108220B
(zh)
|
2017-03-15 |
2024-11-19 |
博德研究所 |
用于病毒检测的基于crispr效应系统的诊断
|
|
US10934336B2
(en)
|
2017-04-13 |
2021-03-02 |
The Trustees Of The University Of Pennsylvania |
Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy
|
|
US10415017B2
(en)
|
2017-05-17 |
2019-09-17 |
Thunder Biotech, Inc. |
Transgenic macrophages, chimeric antigen receptors, and associated methods
|
|
CA3067244A1
(en)
|
2017-06-12 |
2018-12-20 |
Children's Healthcare Of Atlanta, Inc. |
T-cell antigen targeted chimeric antigen receptor (car) and uses in cell therapies
|
|
TW201904588A
(zh)
|
2017-06-25 |
2019-02-01 |
美商西雅圖免疫公司 |
引導及導航控制蛋白質之製造及使用方法
|
|
WO2019010551A1
(pt)
|
2017-07-10 |
2019-01-17 |
Instituto De Biologia Molecular Do Paraná - Ibmp |
Plataforma genética para superexpressão heteróloga associada à seleção de células altamente produtoras de proteínas
|
|
EP3658589B1
(en)
|
2017-07-26 |
2023-09-27 |
Forty Seven, Inc. |
Anti-sirp-alpha antibodies and related methods
|
|
CN109337872B
(zh)
|
2017-07-27 |
2023-06-23 |
上海细胞治疗研究院 |
高效扩增car-t细胞的人工抗原递呈细胞及其用途
|
|
CN109306340B
(zh)
|
2017-07-27 |
2023-06-06 |
上海细胞治疗研究院 |
一种高效扩增全t细胞的人工抗原递呈细胞及其用途
|
|
EP3664845A4
(en)
|
2017-08-08 |
2021-03-10 |
Pionyr Immunotherapeutics, Inc. |
COMPOSITIONS AND METHODS OF DEACTIVATION OF MYELOID CELLS EXPRESSING TREM1
|
|
WO2019050948A1
(en)
|
2017-09-05 |
2019-03-14 |
Regeneron Pharmaceuticals, Inc. |
ADMINISTRATION OF A GENE EDITION SYSTEM HAVING ONLY ONE RETROVIRAL PARTICLE AND METHODS OF GENERATING AND USING
|
|
JP2020532987A
(ja)
|
2017-09-08 |
2020-11-19 |
ポセイダ セラピューティクス，インコーポレイティド |
キメラリガンド受容体（ｃｌｒ）介在性の条件遺伝子発現のための組成物および方法
|
|
DK3688032T3
(da)
|
2017-09-26 |
2025-12-15 |
Cero Therapeutics Holdings Inc |
Kimære engulfment-receptormolekyler og anvendelsesfremgangsmåder
|
|
US12467050B2
(en)
|
2017-10-02 |
2025-11-11 |
Georgia Tech Research Corporation |
Methods and compositions for engineering synthetic bioswitches for remote control of biological activity
|
|
WO2019070843A1
(en)
|
2017-10-03 |
2019-04-11 |
Board Of Regents, The University Of Texas System |
INVERSE TRANSCRIPTASE WITH LTR-FREE BACKLIGHTS AND USES THEREOF
|
|
GB201717974D0
(en)
|
2017-10-31 |
2017-12-13 |
Univ Court Of The Univ Of Aberdeen |
Modified receptors
|
|
US20200255829A1
(en)
|
2017-11-02 |
2020-08-13 |
Arbor Biotechnologies, Inc. |
Novel crispr-associated transposon systems and components
|
|
CN109971716B
(zh)
|
2017-12-28 |
2023-08-01 |
上海细胞治疗研究院 |
自分泌cd47抗体的egfr特异性car-t细胞及其用途
|
|
US11572557B2
(en)
|
2018-01-29 |
2023-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Photoreversible acylation reagents
|
|
CA3089991A1
(en)
|
2018-02-02 |
2019-08-08 |
The Trustees Of The University Of Pennsylvania |
Modified monocytes/macrophages/dendritic cells expressing chimeric antigen receptors and uses in diseases and disorders associated with protein aggregates
|
|
CA3092832A1
(en)
|
2018-03-02 |
2019-09-06 |
Generation Bio Co. |
Identifying and characterizing genomic safe harbors (gsh) in humans and murine genomes, and viral and non-viral vector compositions for targeted integration at an identified gsh loci
|
|
GB2572005A
(en)
|
2018-03-16 |
2019-09-18 |
Univ Court Univ Of Edinburgh |
Macrophage-based therapy
|
|
US12291557B2
(en)
|
2018-03-28 |
2025-05-06 |
Cero Therapeutics Holdings, Inc. |
Chimeric TIM4 receptors and uses thereof
|
|
WO2019191332A1
(en)
|
2018-03-28 |
2019-10-03 |
Cero Therapeutics, Inc. |
Chimeric engulfment receptors and uses thereof for neurodegenerative diseases
|
|
RU2020135107A
(ru)
|
2018-03-28 |
2022-04-29 |
Серо Терапьютикс, Инк. |
Клеточные иммунотерапевтические композиции и их применения
|
|
CN112189018A
(zh)
|
2018-04-20 |
2021-01-05 |
汉诺威医学院 |
结合疱疹病毒抗原的嵌合抗原受体和car-t细胞
|
|
EP3813885A4
(en)
|
2018-05-02 |
2022-01-12 |
The Trustees of The University of Pennsylvania |
COMPOSITIONS AND METHODS OF PHOSPHOLIPASE-A2 RECEPTOR CHIMERA AUTOANTIBODY RECEPTOR T CELLS
|
|
SG11202011240YA
(en)
|
2018-06-26 |
2020-12-30 |
Broad Inst Inc |
Crispr/cas and transposase based amplification compositions, systems and methods
|
|
WO2020014303A1
(en)
|
2018-07-11 |
2020-01-16 |
X Gen Us Co. |
Transposome enabled dna/rna-sequencing (ted rna-seq)
|
|
JP2021530212A
(ja)
|
2018-07-13 |
2021-11-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California |
レトロトランスポゾンベースの送達媒体及びその使用方法
|
|
AU2019327449B2
(en)
|
2018-08-28 |
2026-04-09 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
EP3628309A1
(en)
|
2018-09-28 |
2020-04-01 |
Universität Heidelberg |
Method of making oral dosage forms
|
|
GB201818110D0
(en)
|
2018-11-06 |
2018-12-19 |
Macrophox Ltd |
Monocytes for cancer targeting
|
|
EP3876977A1
(en)
|
2018-11-06 |
2021-09-15 |
The Regents Of The University Of California |
Chimeric antigen receptors for phagocytosis
|
|
WO2020131862A1
(en)
*
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Crispr-associated transposase systems and methods of use thereof
|
|
AU2019404302A1
(en)
|
2018-12-19 |
2021-08-05 |
The Trustees Of The University Of Pennsylvania |
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor t cells against t cell lymphomas and leukemias
|
|
WO2020131662A1
(en)
|
2018-12-19 |
2020-06-25 |
Amgen Inc. |
Apparatus for resolving imaging problems caused by the meniscus
|
|
KR20210116526A
(ko)
*
|
2019-01-16 |
2021-09-27 |
빔 테라퓨틱스, 인크. |
증진된 항-신생물 활성 및 면역억제 내성을 갖는 변형된 면역 세포
|
|
US20220001031A1
(en)
|
2019-04-30 |
2022-01-06 |
Myeloid Therapeutics, Inc. |
Engineered chimeric fusion protein compositions and methods of use thereof
|
|
US20220378824A1
(en)
|
2019-04-30 |
2022-12-01 |
Myeloid Therapeutics, Inc. |
Engineered chimeric fusion protein compositions and methods of use thereof
|
|
US11026973B2
(en)
|
2019-04-30 |
2021-06-08 |
Myeloid Therapeutics, Inc. |
Engineered phagocytic receptor compositions and methods of use thereof
|
|
AU2020266595A1
(en)
|
2019-04-30 |
2021-11-25 |
Create Medicines, Inc. |
Engineered chimeric fusion protein compositions and methods of use thereof
|
|
GB2603044B
(en)
|
2019-06-11 |
2024-08-21 |
Myeloid Therapeutics Inc |
Macrophage specific engager compositions and methods of use thereof
|
|
US20220298495A1
(en)
*
|
2019-06-12 |
2022-09-22 |
Emendobio Inc. |
Novel genome editing tool
|
|
AU2020296190A1
(en)
|
2019-06-19 |
2022-01-06 |
Flagship Pioneering Innovations Vi, Llc |
Methods of dosing circular polyribonucleotides
|
|
CA3147875A1
(en)
|
2019-07-19 |
2021-01-28 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
WO2021046243A2
(en)
|
2019-09-03 |
2021-03-11 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
US20230040216A1
(en)
|
2019-11-19 |
2023-02-09 |
The Broad Institute, Inc. |
Retrotransposons and use thereof
|
|
MX2022007107A
(es)
|
2019-12-11 |
2022-11-14 |
Myeloid Therapeutics Inc |
Composiciones celulares terapeuticas y metodos de preparacion y usos de las mismas.
|
|
US10980836B1
(en)
|
2019-12-11 |
2021-04-20 |
Myeloid Therapeutics, Inc. |
Therapeutic cell compositions and methods of manufacturing and use thereof
|
|
BR112022017715A2
(pt)
|
2020-03-04 |
2022-11-16 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições para modular um genoma
|
|
IL296095A
(en)
|
2020-03-04 |
2022-11-01 |
Flagship Pioneering Innovations Vi Llc |
Improved methods and compositions for genome modulation
|
|
AU2021232005A1
(en)
|
2020-03-04 |
2022-09-29 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
BR112022017735A2
(pt)
|
2020-03-05 |
2022-11-29 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições de supressão de defesa de hospedeiro para modular um genoma
|
|
EP4161536A4
(en)
|
2020-06-04 |
2024-08-14 |
Carisma Therapeutics Inc. |
Novel constructs for chimeric antigen receptors
|
|
MX2022015888A
(es)
|
2020-06-26 |
2023-03-28 |
Carisma Therapeutics Inc |
Transfección de ácido ribonucleico mensajero (arnm) de células inmunitarias.
|
|
JP7868033B2
(ja)
|
2020-08-14 |
2026-06-01 |
セロ・セラピューティクス・ホールディングス・インコーポレイテッド |
キメラｔｉｍ受容体およびその使用
|
|
WO2022067033A1
(en)
|
2020-09-24 |
2022-03-31 |
Flagship Pioneering Innovations V, Inc. |
Compositions and methods for inhibiting gene expression
|
|
EP4240367A4
(en)
|
2020-11-04 |
2024-10-16 |
Myeloid Therapeutics, Inc. |
MODIFIED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
|
|
WO2022241029A1
(en)
|
2021-05-11 |
2022-11-17 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|